170 related articles for article (PubMed ID: 3073760)
1. Influence of the specific antagonist of PAF-acether, BN 52021, and of Ginkgo extract on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
Becker K; Braquet P; Förster W
Biomed Biochim Acta; 1988; 47(10-11):S165-8. PubMed ID: 3073760
[TBL] [Abstract][Full Text] [Related]
2. Influence of the specific antagonist of PAF-acether, BN 52021, on the rejection of murine tail skin allografts and the PAF-acether mortality in mice in particular consideration of the role of TXB2.
Becker K; Lueddeckens G; Braquet P; Förster W
Prog Clin Biol Res; 1989; 301():499-503. PubMed ID: 2798460
[No Abstract] [Full Text] [Related]
3. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
Becker K; Förster W
Biomed Biochim Acta; 1988; 47(10-11):S169-72. PubMed ID: 3248104
[TBL] [Abstract][Full Text] [Related]
4. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
5. Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.
Braquet P
Adv Prostaglandin Thromboxane Leukot Res; 1986; 16():179-98. PubMed ID: 2949548
[No Abstract] [Full Text] [Related]
6. Interference of BN 52021 (ginkgolide B) with the bronchopulmonary effects of PAF-acether in the guinea-pig.
Desquand S; Touvay C; Randon J; Lagente V; Vilain B; Maridonneau-Parini I; Etienne A; Lefort J; Braquet P; Vargaftig BB
Eur J Pharmacol; 1986 Aug; 127(1-2):83-95. PubMed ID: 3019727
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human lymphocyte proliferation and interleukin 2 production by platelet activating factor (PAF-acether): reversal by a specific antagonist, BN 52021.
Rola-Pleszczynski M; Pignol B; Pouliot C; Braquet P
Biochem Biophys Res Commun; 1987 Feb; 142(3):754-60. PubMed ID: 3493773
[TBL] [Abstract][Full Text] [Related]
8. Effect of BN 52021, a specific antagonist of platelet activating factor (PAF-acether), on calcium movements and phosphatidic acid production induced by PAF-acether in human platelets.
Simon MF; Chap H; Braquet P; Douste-Blazy L
Thromb Res; 1987 Feb; 45(4):299-309. PubMed ID: 3576518
[TBL] [Abstract][Full Text] [Related]
9. Protection by two ginkgolides, BN-52020 and BN-52021, against guinea-pig lung anaphylaxis.
Berti F; Omini C; Rossoni G; Braquet P
Pharmacol Res Commun; 1986 Sep; 18(9):775-93. PubMed ID: 3099317
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of plasma protein leakage and Salmonella enteritidis-induced mortality in the rat by a specific paf-acether antagonist: BN 52021.
Etienne A; Hecquet F; Soulard C; Spinnewyn B; Clostre F; Braquet P
Agents Actions; 1986 Jan; 17(3-4):368-70. PubMed ID: 3515870
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba.
Lamant V; Mauco G; Braquet P; Chap H; Douste-Blazy L
Biochem Pharmacol; 1987 Sep; 36(17):2749-52. PubMed ID: 2820421
[TBL] [Abstract][Full Text] [Related]
13. The effects of PAF-acether on the cardiovascular system and their inhibition by a new highly specific PAF-acether receptor antagonist BN 52021.
Baranes J; Hellegouarch A; Le Hegarat M; Viossat I; Auguet M; Chabrier PE; Braquet P
Pharmacol Res Commun; 1986 Aug; 18(8):717-37. PubMed ID: 3763677
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of a novel platelet activating factor (PAF) antagonist (BN 52021) on antigen-induced prostaglandin and thromboxane formation by the guinea pig lung.
Harczy M; Maclouf J; Pradelles P; Braquet P; Borgeat P; Sirois P
Pharmacol Res Commun; 1986 Aug; 18 Suppl():111-7. PubMed ID: 3095849
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
16. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988.
Nunez D; Chignard M; Korth R; Le Couedic JP; Norel X; Spinnewyn B; Braquet P; Benveniste J
Eur J Pharmacol; 1986 Apr; 123(2):197-205. PubMed ID: 3086108
[TBL] [Abstract][Full Text] [Related]
17. Thrombus induction by endogenic paf-acether and its inhibition by Ginkgo Biloba extracts in the guinea pig.
Bourgain RH; Maes L; Andries R; Braquet P
Prostaglandins; 1986 Jul; 32(1):142-4. PubMed ID: 3763943
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba.
Touvay C; Etienne A; Braquet P
Agents Actions; 1986 Jan; 17(3-4):371-2. PubMed ID: 3754380
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor antagonists treatment protects against postischemic acute renal failure in rats.
López-Farré A; Bernabeu F; Gómez-Garre D; Ramon y Cajal S; Braquet P; López-Novoa JM
J Pharmacol Exp Ther; 1990 Apr; 253(1):328-33. PubMed ID: 2329516
[TBL] [Abstract][Full Text] [Related]
20. Characterization of platelet activating factor (PAF)-acether-induced contractions of guinea-pig lung strips by selected inhibitors of arachidonic acid metabolism and by PAF-acether antagonists.
Touvay C; Vilain B; Etienne A; Sirois P; Borgeat P; Braquet P
Immunopharmacology; 1986 Oct; 12(2):97-104. PubMed ID: 3021651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]